28 Apr 2025
💊DEA Notice on Controlled Substances Application Correction
Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US), LLC; Correction
Summary
The Drug Enforcement Administration (DEA) published a document in the Federal Register on March 26, 2025, concerning a notice of application for bulk manufacturer of Controlled Substances. As that document indicated the registrant's incorrect plans for the listed controlled substances.
Agencies
- Justice Department
- Drug Enforcement Administration
Business Impact
$$ - Med
The document details a correction regarding the DEA's approval of bulk manufacturing of controlled substances, specifically Noroxymorphone and Oxymorphone. Business owners in the pharmaceutical sector must be aware of regulatory compliance requirements to avoid disruptions in production and sales, impacting financial planning and operational strategies.